Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgG1 (AM130) (Trehalose free) (MALS verified), Unconjugated 100 mg

Produktübersicht

• Artikelname: Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgG1 (AM130) (Trehalose free) (MALS verified), Unconjugated 100 mg
• Artikelnummer: ABS-S1N-M13A1-100MG
• Hersteller Artikelnummer: S1N-M13A1-100mg
• Alternativnummer: ABS-S1N-M13A1-100MG
• Hersteller: AcroBiosystems
• Wirt: Human
• Kategorie: Antikörper
• Spezies Reaktivität: Mouse
• Konjugation: Unconjugated

Produktbeschreibung

AntiSARSCoV2 Spike RBD Antibody, Chimeric mAb, Human IgG1 (AM130) (S1NM13A1) is a chimeric monoclonal antibody combining the constant domains of the human IgG1 molecule with mouse variable regions. The variable region was obtained from a mouse immunized with purified recombinant SARSCoV2 Spike S1 Protein. - Antikörper

Produkteigenschaften

• Tag: Human IgG1 | Human Kappa
• Puffer: PBS, pH7.4
• Reinheit: 0.95
• Formulierung: Liquid
• Target-Kategorie: Spike RBD

Bilder

Immobilized SARS-CoV-2 S1 protein, His Tag (Cat. No. S1N-C52H2) at 2 µg/mL (100 µL/well) can bind Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgG1 (AM130) (Cat. No. S1N-M13A1) with a linear range of 0.078-1.25 ng/mL (QC tested).

Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgG1 (AM130) on SDS-PAGE under reducing (R) and under non-reducing (NR) conditions. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 0.95.